616466 | InhibitorSelect™ TGF-βR and BMPR Signaling Pathway Inhibitor Panel

616466
Le prix n'a pas pu être récupéré
Minimum Quantity needs to be mulitiple of
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
Demander le prix
Disponibilité limitéeDisponibilité limitée
En stock
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Remaining : Will advise
      Nous vous tiendrons informé
      Voir les Prix & la Disponibilité
         ComparerClick To Print This Page

      Overview

      Replacement Information

      Tableau de caractéristiques principal

      Prix & Disponibilité

      RéférenceDisponibilité Conditionnement Qté Prix Quantité
      616466-1EA
      Récupération des données relatives à la disponibilité...
      Disponibilité limitéeDisponibilité limitée
      En stock
      Interrompu(e)
      Disponible en quantités limitées
      Disponibilité à confirmer
        Remaining : Will advise
          Nous vous tiendrons informé

          1 ea
          Prix en cours de récupération
          Le prix n'a pas pu être récupéré
          Minimum Quantity needs to be mulitiple of
          À la validation de la commande Plus d'informations
          Vous avez sauvegardé ()
           
          Demander le prix
          Description
          Overview A panel containing 18 potent, selective and cell-permeable inhibitors that are useful for the study of TGF-βR and BMPR signaling pathway: 2 mg of Akt Inhibitor XIII, Isozyme-Selective, Akti2-1/2 (Cat. No. 124030), 1 mg of Dorsomorphin (AMPK Inhibitor, Compound C; Cat. No. 171260), 5 mg of ET-18-OCH3 (Cat. No. 341207), 5 mg of IRAK-1/4 Inhibitor (Cat. No. 407601), 500 µg of JAK Inhibitor I, Pyridone 6 (Cat. No. 420099), 5 mg of MG-132 (Cat. No. 474790), 1 mg of (5Z)-7-Oxozeaenol, Curvularia sp. (Cat. No. 499610), 5 mg of p21-Activated Kinase Inhibitor III, IPA-3 (Cat. No. 506106), 1 mg of PD 169316 (Cat. No. 513030), 1 mg of PI-103 (Cat. No. 528100), 5 mg of Rac1 Inhibitor (Cat. No. 553502), 500 µg of Ro-31-8220 (Cat. No. 557520), 1 mg of Smad3 Inhibitor, SIS3 (Cat. No. 566405), 10 mg of STAT3 Inhibitor III, WP1066 (Cat. No. 573097), 1 mg of TGF-β RI Kinase Inhibitor II (Cat. No. 616452), 5 mg of TGF-β RI Kinase Inhibitor VI, SB431542 (Cat. No. 616461), 1 mg of U0126 (Cat. No. 662005), 1 mg of Y-27632 (Cat. No. 688000). Also provided with 15 ml of anhydrous DMSO (Cat. No. KP31817). Supplied with a data sheet.
          Catalogue Number 616466
          Brand Family Calbiochem®
          Application Data

          References
          References Pardali, E., et al. 2010. Trends Cell Biol. 20, 556.
          Mosse, Y.P., et al. 2009. Clin. Cancer Res. 15, 5609.
          Clarke, D.C. and Liu, X., 2008 Trends Cell Biol. 18, 430.
          Product Information
          Form Solid
          Hygroscopic Hygroscopic
          Applications
          Biological Information
          Physicochemical Information
          Solubility DMSO
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Shipped with Blue Ice or with Dry Ice
          Toxicity Regulatory Review
          Storage -20°C
          Protect from Light Protect from light
          Hygroscopic Hygroscopic
          Do not freeze No
          Special Instructions Following reconstitution, aliquot and freeze (-20°C) each inhibitor. Each inhibitor solution is stable for up to 3 months at -20°C.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          Certificats d'analyse

          TitreNuméro de lot
          616466

          Références bibliographiques

          Aperçu de la référence bibliographique
          Pardali, E., et al. 2010. Trends Cell Biol. 20, 556.
          Mosse, Y.P., et al. 2009. Clin. Cancer Res. 15, 5609.
          Clarke, D.C. and Liu, X., 2008 Trends Cell Biol. 18, 430.
          Fiche technique

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision 21-July-2011 RFH
          Application Data

          Description A panel containing 18 potent, selective and cell-permeable inhibitors that is useful for the study of TGF-βR and BMPR signaling pathway. This panel contains the following inhibitors as well as 15 ml anhydrous DMSO for reconstitution:
          Form Solid
          Intert gas (Yes/No) Packaged under inert gas
          Solubility DMSO (supplied). Please refer to information provided on the CD for reconstitution information of individual inhibitors.
          Storage -20°C
          Protect from light
          Hygroscopic
          Do Not Freeze No
          Special Instructions Following reconstitution, aliquot and freeze (-20°C) each inhibitor. Each inhibitor solution is stable for up to 3 months at -20°C.
          Toxicity Regulatory Review
          References Pardali, E., et al. 2010. Trends Cell Biol. 20, 556.
          Mosse, Y.P., et al. 2009. Clin. Cancer Res. 15, 5609.
          Clarke, D.C. and Liu, X., 2008 Trends Cell Biol. 18, 430.